Lateral Diffusion of Ibuprofen in Human Skin during Permeation Studies

Skin Pharmacology and Physiology

Volumn 17, Issue 2, 2004, Pages 84-90

  Schicksnus, G ^a   Muller Goymann C C ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Artificial skin construct; Excised human skin; High performance liquid chromatography UV; Ibuprofen; Lateral diffusion

Indexed keywords

IBUPROFEN; IBUTOP CREME;

ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DIFFUSION; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SKIN PERMEABILITY; STRATUM CORNEUM;

BIOLOGICAL TRANSPORT; DIFFUSION; DIMETHYL SULFOXIDE; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; HUMANS; IBUPROFEN; MODELS, BIOLOGICAL; OINTMENTS; PERMEABILITY; SKIN; SKIN ABSORPTION; SKIN PHYSIOLOGY; UREA;

EID: 1342301595     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076018     Document Type: Article

References (13)

1. Franz TJ: Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 1975;64:190-195.
2. Poulsen BJ, Young E, Coquilla V, Katz M: Effect of topical vehicle composition on in vitro release of fluocinolone acetonide and its acetate ester. J Pharm Sci 1968;57:928-933.
3. Barry BW: Mode of action of penetration enhancers in human skin. J Control Release 1987;6:85-97.
4. Specht C, Stoye I, Müller-Goymann CC: Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies. Eur J Pharm Biopharm 1998;46:273-278.
5. Bartek MJ, La Budde JA, Maibach HI: Skin permeability in vivo: Comparison in rat, rabbit, pig and man. J Invest Dermatol 1972;58:114-123.
6. Wassermann K, Müller-Goymann CC: Standardized cultivation of artificial skin constructs for drug permeation studies. Arch Pharm Pharm Med Chem 2000;333(suppl 1):34.
7. Mak VHW, Cumpstone MB, Kennedy AH, Harmon CH, Guy RH, Potts RO: Barrier function of human keratinocyte cultures grown at the air-liquid interface. J Invest Dermatol 1991;96:323-327.
8. Ponec M, Wauben-Penris PJJ, Burger A, Kempenaar J, Boddè HE: Nitroglycerin and sucrose permeability as quality markers for reconstructed human epidermis. Skin Pharmacol 1990;3:126-135.
9. Flynn GC, Yalkowsky SH, Rosemann TJ: Mass transport phenomena and models: Theoretical concepts. J Pharm Sci 1974;63:479-510.
10. Johnson ME, Berk DA, Blankschtein D, Golan DE, Jain RK, Langer RS: Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems. Biophysical J 1996;71:2656-2668.
11. Johnson ME, Blankschtein D, Langer R: Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci 1997;86:1162-1172.
12. Weigmann HJ, Lademann J, v Pelchrzim R, Sterry W, Hagemeister T, Molzahn R, Schaefer M, Lindscheid M, Schaefer H, Shah VP: Bioavailability of clobetasol propionate - quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping. Skin Pharmacol Appl Skin Physiol 1999;12:46-53.
13. Simonsen L, Petersen MB, Benfeldt E, Serup J: Development of an in vivo animal model for skin penetration in hairless rats assessed by mass balance. Skin Pharmacol Appl Skin Physiol 2002;15:414-424.